Your browser doesn't support javascript.
loading
Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers.
May, Folasade P; Brodney, Suzanne; Tuan, Jessica J; Syngal, Sapna; Chan, Andrew T; Glenn, Beth; Johnson, Gina; Chang, Yuchiao; Drew, David A; Moy, Beverly; Rodriguez, Nicolette J; Warner, Erica T; Anyane-Yeboa, Adjoa; Ukaegbu, Chinedu; Davis, Anjelica Q; Schoolcraft, Kimberly; Regan, Susan; Yoguez, Nathan; Kuney, Samantha; Le Beaux, Kelley; Jeffries, Catherine; Lee, Ellen T; Bhat, Roopa; Haas, Jennifer S.
Afiliação
  • May FP; Department of Medicine, David Geffen School of Medicine, UCLA Ronald Reagan Medical Center, University of California Los Angeles, 757 Westwood Plaza, Los Angeles, CA 90095, USA; Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Univer
  • Brodney S; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Tuan JJ; UCLA Kaiser Permanente Center for Health Equity, Jonsson Comprehensive Cancer Center, 650 S. Charles E Young Drive, Center for Health Sciences, Suite A2-125, Los Angeles, CA 90095-6900, USA.
  • Syngal S; Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA; Population Sciences and Cancer Genetics and Prevention Divisions, Dana Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Channing
  • Glenn B; UCLA Kaiser Permanente Center for Health Equity, Jonsson Comprehensive Cancer Center, 650 S. Charles E Young Drive, Center for Health Sciences, Suite A2-125, Los Angeles, CA 90095-6900, USA; Department of Health Policy and Management, UCLA Fielding School of Public Health, United States of America;
  • Johnson G; Community Health Prevention Programs, Great Plains Tribal Leaders Health Board, Rapid City, SD, USA.
  • Chang Y; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Drew DA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Moy B; Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Rodriguez NJ; Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Warner ET; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Mongan Institute, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U
  • Anyane-Yeboa A; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Ukaegbu C; Population Sciences and Cancer Genetics and Prevention Divisions, Dana Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Davis AQ; Fight Colorectal Cancer, 134 Park Central Sq. Ste 210, Springfield, MO 65806, USA.
  • Schoolcraft K; Fight Colorectal Cancer, 134 Park Central Sq. Ste 210, Springfield, MO 65806, USA.
  • Regan S; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Yoguez N; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Kuney S; Population Sciences and Cancer Genetics and Prevention Divisions, Dana Farber Cancer Institute, Boston, MA, USA.
  • Le Beaux K; Community Health Prevention Programs, Great Plains Tribal Leaders Health Board, Rapid City, SD, USA.
  • Jeffries C; Community Health Prevention Programs, Great Plains Tribal Leaders Health Board, Rapid City, SD, USA.
  • Lee ET; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Bhat R; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Haas JS; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; Mongan Institute, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: Jennifer.Haas@mgh.harvard.edu.
Contemp Clin Trials ; 145: 107639, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39068985
ABSTRACT

INTRODUCTION:

Colorectal cancer (CRC) screening utilization is low among low-income, uninsured, and minority populations that receive care in community health centers (CHCs). There is a need for evidence-based interventions to increase screening and follow-up care in these settings.

METHODS:

A multilevel, multi-component pragmatic cluster randomized controlled trial is being conducted at 8 CHCs in two metropolitan areas (Boston and Los Angeles), with two arms (1) Mailed FIT outreach with text reminders, and (2) Mailed FIT-DNA with patient support. We also include an additional CHC in Rapid City (South Dakota) that follows a parallel protocol for FIT-DNA but is not randomized due to lack of a comparison group. Eligible individuals in participating clinics are primary care patients ages 45-75, at average-risk for CRC, and overdue for CRC screening. Participants with abnormal screening results are offered navigation for follow-up colonoscopy and CRC risk assessment.

RESULTS:

The primary outcome is the completion rate of CRC screening at 90 days. Secondary outcomes include the screening completion rate at 180 days and the rate of colonoscopy completion within 6 months among participants with an abnormal result. Additional goals are to enhance our understanding of facilitators and barriers to CRC risk assessment in CHC settings.

CONCLUSIONS:

This study assesses the effectiveness of two multilevel interventions to increase screening participation and follow-up after abnormal screening in under-resourced clinical settings, informing future efforts to address CRC disparities. TRIAL REGISTRATION NCT05714644.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colonoscopia / Centros Comunitários de Saúde / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colonoscopia / Centros Comunitários de Saúde / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2024 Tipo de documento: Article